|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1994-5-13
|
|
pubmed:abstractText |
Patients with relapsed germ cell cancer (GCT) have a poor prognosis when treated solely with conventional chemotherapy; high dose chemotherapy with autologous bone marrow rescue (ABMR) has shown curative potential in patients with relapsed and refractory GCT. This protocol was designed to incorporate high dose therapy with initial salvage therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1716-20
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7512438-Adolescent,
pubmed-meshheading:7512438-Adult,
pubmed-meshheading:7512438-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7512438-Bleomycin,
pubmed-meshheading:7512438-Bone Marrow Transplantation,
pubmed-meshheading:7512438-Cisplatin,
pubmed-meshheading:7512438-Combined Modality Therapy,
pubmed-meshheading:7512438-Cyclophosphamide,
pubmed-meshheading:7512438-Dactinomycin,
pubmed-meshheading:7512438-Etoposide,
pubmed-meshheading:7512438-Female,
pubmed-meshheading:7512438-Follow-Up Studies,
pubmed-meshheading:7512438-Humans,
pubmed-meshheading:7512438-Ifosfamide,
pubmed-meshheading:7512438-Male,
pubmed-meshheading:7512438-Middle Aged,
pubmed-meshheading:7512438-Neoplasms, Germ Cell and Embryonal,
pubmed-meshheading:7512438-Remission Induction,
pubmed-meshheading:7512438-Salvage Therapy,
pubmed-meshheading:7512438-Testicular Neoplasms,
pubmed-meshheading:7512438-Transplantation, Autologous,
pubmed-meshheading:7512438-Vinblastine
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
|
|
pubmed:affiliation |
Indiana University Hospital, Indianapolis 46202.
|
|
pubmed:publicationType |
Journal Article
|
